Skip to main content

Advertisement

Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate

Fig. 3

Kaplan survival curve free for stroke events (upper part), and ventricular tachycardia (VT) events (lower part) event in GLP-1 agonist users (blu color), and non GLP-1 agonist users (green color). *p value < 0.05 for VT events

Back to article page